Diclofenac Dosing and Controlled Medication Accountability Failures
Summary
The facility failed to ensure that manufacturer instructions were followed when administering diclofenac sodium topical gel to two residents. Resident 24 was admitted with diagnoses including osteoarthritis, psoriatic arthritis mutilans, prurigo nodularis, and acne keloid, and the record showed the resident lacked capacity to understand and make decisions. The resident’s orders included diclofenac gel for breast pain, joint pain, and chest keloid pain. During medication pass observation, an LVN squeezed the gel directly into a medication cup and applied the full amount to the resident’s chest instead of using the manufacturer’s dosing card. The unused dosing card remained glued inside the carton. The LVN stated the resident reported itching from the gel and that the gel was not being measured with the dosing card. The ADON stated the dosing card must be used and that estimating the dose in a cup was not acceptable. Resident 123 was admitted with osteoarthritis, bilateral shoulder pain, neuropathy, and pain related to nervous system prosthetic devices and implants. The resident’s history and physical indicated the resident lacked capacity for medical decision making due to chronic encephalopathy from CVA, and the MDS showed moderate cognitive impairment. The resident had an order for diclofenac sodium external gel 1% to both shoulders twice daily at 2 gm. During medication cart review and interview, an LVN stated she squeezed the gel into a medication cup and applied whatever amount was in the cup to both shoulders. She stated she did not use the dosing card and did not know it was inside the packaging. The dosing card was still taped inside the carton unused. The LVN stated accurate dosing was important to avoid side effects and to ensure effectiveness, and the DON stated nurses must use the dosing card to measure the ordered amount. The facility also failed to follow controlled medication accountability procedures on Station 3. An LVN signed the shift change Controlled Drugs Count Record and Narcotic Accountability forms ahead of time, before the end of the shift and without the incoming nurse present. The LVN stated she should have waited and signed together with the incoming nurse. The DON stated both nurses must endorse the forms together and review the medication cart and controlled medications together before the incoming nurse assumes responsibility. In addition, the facility did not follow its Cubex blind count procedure. During inspection, staff demonstrated that the Cubex displayed the available quantity before removal of medication, and the DON stated there was no blind count in practice. The facility’s Cubex policy stated that prior to removing a medication, the user enters the inventory count and discrepancies are logged if the counts do not match.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.